EMA — authorised 19 September 2005
- Marketing authorisation holder: ROCHE REGISTRATION GMBH
- Status: approved
EMA authorised Tarceva on 19 September 2005
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 19 September 2005.
ROCHE REGISTRATION GMBH holds the EU marketing authorisation.